VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Bolt Biotherapeutics, Inc. (BOLT) Total Return Calculator with Dividends Reinvested

Bolt Biotherapeutics, Inc.

Popular:

The total return for Bolt Biotherapeutics, Inc. (BOLT) stock is -29.77% over the past 12 months. So far it's down 16.06% this year. The 5-year total return is -98.99%, meaning $10,000 invested in BOLT stock 5 years ago would be worth $101 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in BOLT 1 year ago, it would be worth $6,983 today — you'd have lost $3,017.

With Dividends Reinvested$6,983-30.17%

Price Only (No DRIP)$6,983-30.17%

Period2025-05-06 → 2026-05-05

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in BOLT

1Y$7,023-$2,977 (-29.8%)-29.8% CAGR

3Y$1,509-$8,491 (-84.9%)-46.8% CAGR

5Y$101-$9,899 (-99.0%)-60.1% CAGR

10Y$76-$9,924 (-99.2%)-38.6% CAGR

15Y$88-$9,912 (-99.1%)-27.0% CAGR

20Y$88-$9,912 (-99.1%)-21.1% CAGR

30Y$88-$9,912 (-99.1%)-14.6% CAGR

Bolt Biotherapeutics, Inc. did not pay dividends during this period. Total return = price return.

Loading BOLT total return...

As of 2026-05-06

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-16.06%	—	-16.06%	—	$8,394
1Y	-29.77%	-29.77%	-29.77%	—	$7,023
3Y	-84.91%	-46.76%	-84.91%	—	$1,509
5Y	-98.99%	-60.14%	-98.99%	—	$101
10Y	-99.24%	-38.65%	-99.24%	—	$76
15Y	-99.12%	-27.03%	-99.24%	+0.13 pp	$88
20Y	-99.12%	-21.05%	-99.24%	+0.13 pp	$88
30Y	-99.12%	-14.58%	-99.24%	+0.13 pp	$88

Risk & Highlights

Best Year-18.25%2023

Worst Year-84.76%2021

Max Drawdown-47.16%2025-05-12 → 2026-03-13

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-21.93%	-21.93%	—	+0.41%	-22.3pp
2025	-52.04%	-52.04%	—	+16.64%	-68.7pp
2024	-53.88%	-53.88%	—	+24.00%	-77.9pp
2023	-18.25%	-18.25%	—	+24.81%	-43.1pp
2022	-73.03%	-73.03%	—	-19.95%	-53.1pp

BOLT underperformed the S&P 500 by 58.21pp over the past year (-29.77% vs +28.44%).

Loading summary...

BOLT Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
BOLTBolt Biotherapeutics, Inc.	$9M	-1.4%	-16.1%	-29.8%	—	-84.9%	-99.0%	-99.2%
RCUSArcus Biosciences, Inc.	$2.6B	+17.2%	+11.9%	+191.5%	—	+33.2%	-15.8%	+53.3%
AGENAgenus Inc.	$147M	+10.6%	+29.1%	+35.0%	—	-86.7%	-92.9%	-93.3%
IMVTImmunovant, Inc.	$5.7B	+11.9%	+7.4%	+82.9%	—	+45.0%	+69.8%	+179.8%
TGTXTG Therapeutics, Inc.	$5.7B	+7.2%	+23.3%	-4.2%	—	+5.3%	-13.0%	+343.5%
SNDXSyndax Pharmaceuticals, Inc.	$1.8B	-17.2%	-5.6%	+48.1%	—	+0.2%	+30.4%	+43.5%
NKTRNektar Therapeutics	$1.7B	+12.6%	+93.8%	+716.3%	—	+584.2%	-70.0%	-58.9%
FATEFate Therapeutics, Inc.	$272M	+98.3%	+138.4%	+101.7%	—	-58.5%	-97.0%	+39.6%
ALNYAlnylam Pharmaceuticals, Inc.	$40.2B	-8.8%	-24.8%	+10.1%	—	+42.0%	+127.0%	+412.7%
XNCRXencor, Inc.	$924M	+3.3%	-13.9%	+19.9%	—	-53.1%	-68.5%	+14.1%
MGNXMacroGenics, Inc.	$199M	-0.9%	+95.7%	+92.1%	—	-55.7%	-90.4%	-83.3%

Compare:BOLT vs RCUS BOLT vs AGEN BOLT vs IMVT BOLT vs RCUS vs AGEN

About BOLT Dividend Returns

Bolt Biotherapeutics, Inc. (BOLT) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of BOLT over the past year?

Bolt Biotherapeutics, Inc. (BOLT) delivered a return of -29.77% over the past year. Since BOLT does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in BOLT be worth today?

A $10,000 investment in Bolt Biotherapeutics, Inc. one year ago would be worth $7,023 today, representing a loss of $2,977.

Q3Does BOLT pay dividends?

Bolt Biotherapeutics, Inc. (BOLT) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For BOLT, the total return equals the price-only return.

Q4Did BOLT beat the S&P 500?

No, Bolt Biotherapeutics, Inc. (BOLT) underperformed the S&P 500 by 58.21 percentage points over the past year. BOLT delivered a total return of -29.77%, compared to the S&P 500's 28.44%. This means a passive S&P 500 index fund outperformed BOLT by 58.21pp during this period.

Q5What is BOLT's worst drawdown?

Bolt Biotherapeutics, Inc. (BOLT) experienced a maximum drawdown of -47.16% over the past year, declining from its peak on 2025-05-12 to its trough on 2026-03-13. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is BOLT's long-term total return over 10, 20, or 30 years?

Here are Bolt Biotherapeutics, Inc. (BOLT)'s long-term returns with dividends reinvested. Over 10 years, the total return is -99.2% (-38.6% CAGR) — $10,000 would have grown to $76. Over 20 years: -99.1% total return (-21.1% CAGR) — $10,000 → $88. Over 30 years: -99.1% total return (-14.6% CAGR) — $10,000 → $88. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was BOLT's best and worst year?

Bolt Biotherapeutics, Inc.'s best calendar year was 2023 with a total return of -18.2%. Its worst year was 2021 with a total return of -84.8%. This range shows the volatility investors should expect — the difference between the best and worst year is 66.5 percentage points.